TNDM Tandem Diabetes Care Inc

$19.50

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 11/21/2025

About Tandem Diabetes Care Inc

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and markets various products for people with insulin-dependent diabetes in the United States. The company is headquartered in San Diego, California.

Website: https://www.tandemdiabetes.com

Sector
LIFE SCIENCES
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1438133
Address
11075 ROSELLE STREET, SAN DIEGO, CA, US
Valuation
Market Cap
$1.12B
P/E Ratio
nan
PEG Ratio
0.00
Price to Book
4.27
Performance
EPS
$-1.47
Dividend Yield
—
Profit Margin
-10.20%
ROE
-33.30%
Technicals
50D MA
$22.92
200D MA
$34.10
52W High
$53.69
52W Low
$15.75
Fundamentals
Shares Outstanding
67M
Target Price
$39.33
Beta
1.53

TNDM EPS Estimates vs Actual

● Estimated
● Actual

TNDM News & Sentiment

Nov 20, 2025 • Benzinga NEUTRAL
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. ( NASDAQ: TNDM ) , You Are Encouraged to Contact The Rosen Law Firm About Your Rights - Tandem Diabetes Care ( NASDAQ:TNDM )
NEW YORK, Nov. 19, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. ( NASDAQ:TNDM ) resulting from allegations that Tandem Diabetes Care may have ...
Nov 06, 2025 • Zacks Commentary NEUTRAL
Tandem Diabetes Care, Inc. ( TNDM ) Reports Q3 Loss, Tops Revenue Estimates
Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of 0.00% and +4.83%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Nov 01, 2025 • Business Insider NEUTRAL
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation ...
Oct 30, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Tandem Diabetes Care, Inc. ( TNDM ) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Tandem Diabetes Care (TNDM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Oct 29, 2025 • Zacks Commentary SOMEWHAT-BULLISH
AxoGen ( AXGN ) Q3 Earnings and Revenues Top Estimates
AxoGen (AXGN) delivered earnings and revenue surprises of +33.33% and +5.32%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Oct 28, 2025 • Benzinga SOMEWHAT-BEARISH
DexCom Faces New Reports Of Deaths Linked To G7 Glucose Monitor - DexCom ( NASDAQ:DXCM )
DexCom Inc ( NASDAQ:DXCM ) is facing renewed scrutiny after three people with diabetes reportedly died following issues with its G7 continuous glucose monitor, according to adverse event filings submitted to the Food and Drug Administration in September.
Sentiment Snapshot

Average Sentiment Score:

0.074
50 articles with scored sentiment

Overall Sentiment:

Neutral

TNDM Reported Earnings

Aug 06, 2025
Jun 30, 2025 (Pre market)
-0.38 Surprise
  • Reported EPS: $-0.78
  • Estimate: $-0.40
  • Whisper: —
  • Surprise %: -95.0%
Apr 30, 2025
Mar 31, 2025 (Pre market)
-0.06 Surprise
  • Reported EPS: $-0.67
  • Estimate: $-0.61
  • Whisper: —
  • Surprise %: -9.5%
Feb 26, 2025
Dec 31, 2024 (Post market)
-0.2 Surprise
  • Reported EPS: $-0.44
  • Estimate: $-0.24
  • Whisper: —
  • Surprise %: -84.8%
Nov 06, 2024
Sep 30, 2024 (Post market)
0.05 Surprise
  • Reported EPS: $-0.35
  • Estimate: $-0.40
  • Whisper: —
  • Surprise %: 12.5%
Aug 01, 2024
Jun 30, 2024 (Post market)
0.06 Surprise
  • Reported EPS: $-0.48
  • Estimate: $-0.54
  • Whisper: —
  • Surprise %: 11.1%
May 02, 2024
Mar 31, 2024 (Post market)
0.13 Surprise
  • Reported EPS: $-0.63
  • Estimate: $-0.76
  • Whisper: —
  • Surprise %: 17.1%
Feb 21, 2024
Dec 31, 2023 (Post market)
-0.02 Surprise
  • Reported EPS: $-0.27
  • Estimate: $-0.25
  • Whisper: —
  • Surprise %: -8.0%
Nov 01, 2023
Sep 30, 2023 (Post market)
-0.04 Surprise
  • Reported EPS: $-0.38
  • Estimate: $-0.34
  • Whisper: —
  • Surprise %: -11.8%
Aug 03, 2023
Jun 30, 2023 (Post market)
-0.02 Surprise
  • Reported EPS: $-0.55
  • Estimate: $-0.53
  • Whisper: —
  • Surprise %: -3.8%

Financials